Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol vs propofol respiratory adverse reactions in elderly day-surgery anesthesia
ChiCTR2300074324Phase 4Not yet recruiting
- Sponsor
- Huadong Hospital, Fudan University
- Start
- Sep 2023
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in bronchopulmonary diseases comparing Ciprofol arm with Propofol arm (2 arms). Primary endpoint: Composite respiratory-related adverse reactions during induction. Planned start Sep 2023; status: not yet recruiting.
02
Drugs
ciprofolpropofol
03
Conditions
bronchopulmonary diseases
Beyond the preview
Go deeper on ChiCTR2300074324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074324.